Association of Prior COVID-19 Vaccination With SARS-CoV-2 Infection and Death in Children and Young Persons During the Omicron Variant Period in Brazil.
作者信息
Oliveira Eduardo A, Oliveira Maria Christina L, Simões E Silva Ana Cristina, Colosimo Enrico A, Mak Robert H, Pinhati Clara C, Martelli Hercílio
机构信息
Department of Pediatrics, Health Sciences Postgraduate Program, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
Department of Statistics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
出版信息
JAMA Pediatr. 2023 Jul 31;177(10):1100-2. doi: 10.1001/jamapediatrics.2023.2584.
Abstract
摘要
相似文献
1
Association of Prior COVID-19 Vaccination With SARS-CoV-2 Infection and Death in Children and Young Persons During the Omicron Variant Period in Brazil.巴西奥密克戎变异株流行期间既往新冠病毒疫苗接种与儿童及青少年感染新冠病毒和死亡的关联
JAMA Pediatr. 2023 Jul 31;177(10):1100-2. doi: 10.1001/jamapediatrics.2023.2584.
2
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性：一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
3
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性：一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
4
Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2-11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study.古巴2至11岁儿童在新冠病毒奥密克戎毒株流行期间采用异源SOBERANA-02和SOBERANA-Plus疫苗接种方案的真实世界有效性：一项纵向病例群体研究
Lancet Reg Health Am. 2024 Apr 23;34:100750. doi: 10.1016/j.lana.2024.100750. eCollection 2024 Jun.
5
Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.估计 BNT162b2 疫苗对美国 5 至 11 岁儿童感染德尔塔和奥密克戎变异株的有效性。
JAMA Netw Open. 2022 Dec 1;5(12):e2246915. doi: 10.1001/jamanetworkopen.2022.46915.
6
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study.美国观察性队列研究：COVID-19 疫苗接种和既往 SARS-CoV-2 感染对 12 岁以下儿童感染奥密克戎和严重结局的影响。
Lancet Infect Dis. 2023 Nov;23(11):1257-1265. doi: 10.1016/S1473-3099(23)00272-4. Epub 2023 Jun 16.
7
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study.两剂 BNT162b2 疫苗对巴西和苏格兰青少年中 COVID-19 症状性和重症的有效性：时间依赖性的病例对照研究。
Lancet Infect Dis. 2022 Nov;22(11):1577-1586. doi: 10.1016/S1473-3099(22)00451-0. Epub 2022 Aug 8.
8
Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant.孕期接种新冠疫苗针对循环病毒变体的有效性。
AJOG Glob Rep. 2023 Aug 25;3(4):100264. doi: 10.1016/j.xagr.2023.100264. eCollection 2023 Nov.
9
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.在奥密克戎毒株占主导期间，既往BNT162b2型新冠疫苗接种与儿童及青少年有症状的新冠病毒感染之间的关联
JAMA. 2022 Jun 14;327(22):2210-2219. doi: 10.1001/jama.2022.7493.
10
Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period.应用寿命表方法评估奥密克戎变异期间使用 COVID-19 病例监测数据按年龄划分的 BNT162b2 疫苗衍生免疫的持续时间。
PLoS One. 2023 Sep 20;18(9):e0291678. doi: 10.1371/journal.pone.0291678. eCollection 2023.
引用本文的文献
1
Comparative performance of twelve machine learning models in predicting COVID-19 mortality risk in children: a population-based retrospective cohort study in Brazil.十二种机器学习模型预测儿童新冠病毒疾病死亡率风险的比较性能：巴西一项基于人群的回顾性队列研究
PeerJ Comput Sci. 2025 May 28;11:e2916. doi: 10.7717/peerj-cs.2916. eCollection 2025.
2
Clinical Features and Vaccination Effects among Children with Post-Acute Sequelae of COVID-19 in Taiwan.台湾地区儿童新冠后遗症的临床特征及疫苗接种效果
Vaccines (Basel). 2024 Aug 12;12(8):910. doi: 10.3390/vaccines12080910.
3
Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes.免疫应答对 SARS-CoV-2 mRNA 疫苗加强针的稳定性受 HLA 基因差异剪接的影响。
Sci Rep. 2024 Apr 18;14(1):8982. doi: 10.1038/s41598-024-59259-1.
本文引用的文献
1
Clinical Outcomes of Omicron Variant (B.1.1.529) Infection in Children and Adolescents Hospitalized With COVID-19 in Brazil With Observational Data on the Efficacy of the Vaccines in Adolescents.巴西新冠病毒奥密克戎变种（B.1.1.529）感染的儿童和青少年住院患者的临床结局以及青少年疫苗效力的观察数据
Pediatr Infect Dis J. 2023 Mar 1;42(3):218-225. doi: 10.1097/INF.0000000000003783. Epub 2022 Nov 29.
2
Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2-18 years: an updated systematic review and meta-analysis.儿童和青少年 2-18 岁人群中 COVID-19 疫苗的免疫原性、有效性和安全性：一项更新的系统评价和荟萃分析。
World J Pediatr. 2023 Nov;19(11):1041-1054. doi: 10.1007/s12519-022-00680-9. Epub 2023 Feb 1.
3
Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis.评估 5 至 11 岁儿童接种 mRNA COVID-19 疫苗的疗效和安全性：系统评价和荟萃分析。
JAMA Pediatr. 2023 Apr 1;177(4):384-394. doi: 10.1001/jamapediatrics.2022.6243.
4
Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.mRNA-1273、BNT162b2 和 BBIBP-CorV 疫苗在阿根廷儿童中的有效性，针对 delta 和 omicron 新冠病毒变异株流行期间的感染和死亡：阴性测试、病例对照研究。
BMJ. 2022 Nov 30;379:e073070. doi: 10.1136/bmj-2022-073070.
5
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study.两剂 BNT162b2 疫苗对巴西和苏格兰青少年中 COVID-19 症状性和重症的有效性：时间依赖性的病例对照研究。
Lancet Infect Dis. 2022 Nov;22(11):1577-1586. doi: 10.1016/S1473-3099(22)00451-0. Epub 2022 Aug 8.
6
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.意大利 2022 年 1 月至 4 月的一项回顾性分析：BNT162b2 疫苗在 5-11 岁儿童中预防 SARS-CoV-2 感染和 COVID-19 重症的效果。
Lancet. 2022 Jul 9;400(10346):97-103. doi: 10.1016/S0140-6736(22)01185-0. Epub 2022 Jul 1.
Zotero 插件